91 results
Page 4 of 5
10-K
guix0pv84h
31 Mar 21
Annual report
4:30pm
10-K
EX-10.9
v9hnljg7u3cwg bm1
31 Mar 21
Annual report
4:30pm
S-3
EX-4.3
nrow lo38mzb85b9j
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.4
gf53er 8ymgd8fqd
29 Jan 21
Shelf registration
4:48pm
S-3
1gl8 6gyhw1ik8c
29 Jan 21
Shelf registration
4:48pm
S-8
7p3e66u
22 Jan 21
Registration of securities for employees
4:15pm
8-K/A
EX-99.1
e3l2n1c5z6lj
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
y5cjtrssfpht qcsl
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
wgk6ouh9770fndys wxq
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.1
x1jzz
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.2
l3s2zc85jhqnq bjczc
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
ch3rbfc cc3
2 Nov 20
Prospectus supplement
12:00am